Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$13.31 - $19.86 $199 - $297
-15 Reduced 0.59%
2,546 $50,000
Q4 2022

Feb 10, 2023

SELL
$12.74 - $15.12 $7,720 - $9,162
-606 Reduced 19.13%
2,561 $34,000
Q3 2022

Nov 10, 2022

BUY
$12.93 - $17.17 $25,006 - $33,206
1,934 Added 156.85%
3,167 $43,000
Q2 2022

Aug 12, 2022

SELL
$13.53 - $23.34 $24,245 - $41,825
-1,792 Reduced 59.24%
1,233 $17,000
Q1 2022

May 12, 2022

BUY
$16.14 - $22.6 $11,862 - $16,611
735 Added 32.1%
3,025 $68,000
Q4 2021

Feb 11, 2022

BUY
$18.64 - $36.77 $298 - $588
16 Added 0.7%
2,290 $43,000
Q3 2021

Nov 05, 2021

SELL
$32.83 - $43.0 $3,676 - $4,816
-112 Reduced 4.69%
2,274 $74,000
Q2 2021

Aug 06, 2021

BUY
$34.41 - $44.03 $2,683 - $3,434
78 Added 3.38%
2,386 $101,000
Q1 2021

May 07, 2021

BUY
$37.29 - $47.19 $783 - $990
21 Added 0.92%
2,308 $88,000
Q4 2020

Feb 12, 2021

BUY
$34.3 - $44.09 $4,253 - $5,467
124 Added 5.73%
2,287 $100,000
Q3 2020

Nov 06, 2020

BUY
$27.86 - $39.35 $26,745 - $37,776
960 Added 79.8%
2,163 $85,000
Q2 2020

Aug 07, 2020

SELL
$30.3 - $42.55 $6,090 - $8,552
-201 Reduced 14.32%
1,203 $37,000
Q1 2020

May 08, 2020

SELL
$30.0 - $54.18 $51,630 - $93,243
-1,721 Reduced 55.07%
1,404 $49,000
Q4 2019

Feb 07, 2020

SELL
$42.29 - $52.2 $2.01 Million - $2.48 Million
-47,563 Reduced 93.83%
3,125 $151,000
Q3 2019

Nov 08, 2019

SELL
$42.06 - $51.64 $855,542 - $1.05 Million
-20,341 Reduced 28.64%
50,688 $2.41 Million
Q2 2019

Aug 09, 2019

SELL
$33.93 - $43.66 $72,338 - $93,083
-2,132 Reduced 2.91%
71,029 $0
Q1 2019

May 10, 2019

BUY
$26.74 - $41.32 $1.96 Million - $3.02 Million
73,135 Added 281288.47%
73,161 $0
Q2 2018

Aug 10, 2018

BUY
$21.73 - $33.15 $564 - $861
26 New
26 $0

Others Institutions Holding CSII

About Cardiovascular Systems Inc


  • Ticker CSII
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 41,905,900
  • Description
  • Cardiovascular Systems, Inc., a medical technology company, develops and commercializes solutions to treat peripheral and coronary artery diseases in the United States and internationally. The company offers peripheral artery disease products comprising catheter-based platforms to treat various plaque types in above and below the knee, including...
More about CSII
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.